Neutral endopeptidase modulation of septic shock - PubMed (original) (raw)

Neutral endopeptidase modulation of septic shock

B Lu et al. J Exp Med. 1995.

Abstract

Neutral endopeptidase (NEP; EC. 3.4.24.11) is a type 2 cell surface metalloprotease known by a variety of eponyms, including enkephalinase, common acute lymphoblastic leukemia antigen, and CD10. Identified substrates are largely neural or humoral oligopeptide agonists, and the enzyme functions to terminate signaling by degrading the ligand, analogously to acetylcholine/acetylcholinesterase. Targeted disruption of the NEP locus in mice results in enhanced lethality to endotoxin shock with a pronounced gene dosage effect. The site(s) of action appears downstream from release of tumor necrosis factor and interleukin-1 since NEP-deficient animals demonstrate increased sensitivity to these mediators as well. This unexpected finding indicates an important protective role for NEP in septic shock.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1975 Dec 4;258(5534):454-6 - PubMed
    1. Blood. 1994 Sep 15;84(6):1737-46 - PubMed
    1. Nature. 1980 Feb 7;283(5747):583-5 - PubMed
    1. Nature. 1980 Nov 20;288(5788):286-8 - PubMed
    1. J Exp Med. 1987 Mar 1;165(3):657-63 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources